A Pilot Study of Peripheral Blood Hematopoietic Stem Cell Mobilization With the Combination of Bortezomib and G-CSF in Multiple Myeloma and Non-Hodgkin's Lymphoma Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT02037256

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:38:11.593085+00:00

Published At

2021-05-10T00:00:00+00:00

Record Updated At

2021-05-10

Results Posted At

2021-05-10

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Adult Grade III Lymphomatoid Granulomatosis", "B-cell Chronic Lymphocytic Leukemia", "Contiguous Stage II Adult Burkitt Lymphoma", "Contiguous Stage II Adult Diffuse Large Cell Lymphoma", "Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma", "Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma", "Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma", "Contiguous Stage II Adult Lymphoblastic Lymphoma", "Contiguous Stage II Grade 1 Follicular Lymphoma", "Contiguous Stage II Grade 2 Follicular Lymphoma", "Contiguous Stage II Grade 3 Follicular Lymphoma", "Contiguous Stage II Mantle Cell Lymphoma", "Contiguous Stage II Marginal Zone Lymphoma", "Contiguous Stage II Small Lymphocytic Lymphoma", "Cutaneous B-cell Non-Hodgkin Lymphoma", "Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue", "Intraocular Lymphoma", "Nodal Marginal Zone B-cell Lymphoma", "Noncontiguous Stage II Adult Burkitt Lymphoma", "Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma", "Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma", "Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma", "Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma", "Noncontiguous Stage II Adult Lymphoblastic Lymphoma", "Noncontiguous Stage II Grade 1 Follicular Lymphoma", "Noncontiguous Stage II Grade 2 Follicular Lymphoma", "Noncontiguous Stage II Grade 3 Follicular Lymphoma", "Noncontiguous Stage II Mantle Cell Lymphoma", "Noncontiguous Stage II Marginal Zone Lymphoma", "Noncontiguous Stage II Small Lymphocytic Lymphoma", "Progressive Hairy Cell Leukemia, Initial Treatment", "Recurrent Adult Burkitt Lymphoma", "Recurrent Adult Diffuse Large Cell Lymphoma", "Recurrent Adult Diffuse Mixed Cell Lymphoma", "Recurrent Adult Diffuse Small Cleaved Cell Lymphoma", "Recurrent Adult Grade III Lymphomatoid Granulomatosis", "Recurrent Adult Immunoblastic Large Cell Lymphoma", "Recurrent Adult Lymphoblastic Lymphoma", "Recurrent Grade 1 Follicular Lymphoma", "Recurrent Grade 2 Follicular Lymphoma", "Recurrent Grade 3 Follicular Lymphoma", "Recurrent Mantle Cell Lymphoma", "Recurrent Marginal Zone Lymphoma", "Recurrent Small Lymphocytic Lymphoma", "Refractory Hairy Cell Leukemia", "Refractory Multiple Myeloma", "Small Intestine Lymphoma", "Splenic Marginal Zone Lymphoma", "Stage I Adult Burkitt Lymphoma", "Stage I Adult Diffuse Large Cell Lymphoma", "Stage I Adult Diffuse Mixed Cell Lymphoma", "Stage I Adult Diffuse Small Cleaved Cell Lymphoma", "Stage I Adult Immunoblastic Large Cell Lymphoma", "Stage I Adult Lymphoblastic Lymphoma", "Stage I Grade 1 Follicular Lymphoma", "Stage I Grade 2 Follicular Lymphoma", "Stage I Grade 3 Follicular Lymphoma", "Stage I Mantle Cell Lymphoma", "Stage I Marginal Zone Lymphoma", "Stage I Multiple Myeloma", "Stage I Small Lymphocytic Lymphoma", "Stage II Multiple Myeloma", "Stage III Adult Burkitt Lymphoma", "Stage III Adult Diffuse Large Cell Lymphoma", "Stage III Adult Diffuse Mixed Cell Lymphoma", "Stage III Adult Diffuse Small Cleaved Cell Lymphoma", "Stage III Adult Immunoblastic Large Cell Lymphoma", "Stage III Adult Lymphoblastic Lymphoma", "Stage III Grade 1 Follicular Lymphoma", "Stage III Grade 2 Follicular Lymphoma", "Stage III Grade 3 Follicular Lymphoma", "Stage III Mantle Cell Lymphoma", "Stage III Marginal Zone Lymphoma", "Stage III Multiple Myeloma", "Stage III Small Lymphocytic Lymphoma", "Stage IV Adult Burkitt Lymphoma", "Stage IV Adult Diffuse Large Cell Lymphoma", "Stage IV Adult Diffuse Mixed Cell Lymphoma", "Stage IV Adult Diffuse Small Cleaved Cell Lymphoma", "Stage IV Adult Immunoblastic Large Cell Lymphoma", "Stage IV Adult Lymphoblastic Lymphoma", "Stage IV Grade 1 Follicular Lymphoma", "Stage IV Grade 2 Follicular Lymphoma", "Stage IV Grade 3 Follicular Lymphoma", "Stage IV Mantle Cell Lymphoma", "Stage IV Marginal Zone Lymphoma", "Stage IV Small Lymphocytic Lymphoma", "Untreated Hairy Cell Leukemia", "Waldenstr\u00f6m Macroglobulinemia"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2021-05-10"

protocolSection.identificationModule.nctId

"NCT02037256"

protocolSection.identificationModule.officialTitle

"A Pilot Study of Peripheral Blood Hematopoietic Stem Cell Mobilization With the Combination of Bortezomib and G-CSF in Multiple Myeloma and Non-Hodgkin\u0027s Lymphoma Patients"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["NA"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2021-05-10"

Study condition terms

• Adult Grade III Lymphomatoid Granulomatosis (protocolSection.conditionsModule.conditions)
• B-cell Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
• Contiguous Stage II Adult Burkitt Lymphoma (protocolSection.conditionsModule.conditions)
• Contiguous Stage II Adult Diffuse Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Contiguous Stage II Adult Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
• Contiguous Stage II Grade 1 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
• Contiguous Stage II Grade 2 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
• Contiguous Stage II Grade 3 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
• Contiguous Stage II Mantle Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Contiguous Stage II Marginal Zone Lymphoma (protocolSection.conditionsModule.conditions)
• Contiguous Stage II Small Lymphocytic Lymphoma (protocolSection.conditionsModule.conditions)
• Cutaneous B-cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
• Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue (protocolSection.conditionsModule.conditions)
• Intraocular Lymphoma (protocolSection.conditionsModule.conditions)
• Nodal Marginal Zone B-cell Lymphoma (protocolSection.conditionsModule.conditions)
• Noncontiguous Stage II Adult Burkitt Lymphoma (protocolSection.conditionsModule.conditions)
• Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Noncontiguous Stage II Adult Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
• Noncontiguous Stage II Grade 1 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
• Noncontiguous Stage II Grade 2 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
• Noncontiguous Stage II Grade 3 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
• Noncontiguous Stage II Mantle Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Noncontiguous Stage II Marginal Zone Lymphoma (protocolSection.conditionsModule.conditions)
• Noncontiguous Stage II Small Lymphocytic Lymphoma (protocolSection.conditionsModule.conditions)
• Progressive Hairy Cell Leukemia, Initial Treatment (protocolSection.conditionsModule.conditions)
• Recurrent Adult Burkitt Lymphoma (protocolSection.conditionsModule.conditions)
• Recurrent Adult Diffuse Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Recurrent Adult Diffuse Mixed Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Recurrent Adult Diffuse Small Cleaved Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Recurrent Adult Grade III Lymphomatoid Granulomatosis (protocolSection.conditionsModule.conditions)
• Recurrent Adult Immunoblastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Recurrent Adult Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
• Recurrent Grade 1 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
• Recurrent Grade 2 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
• Recurrent Grade 3 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
• Recurrent Mantle Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Recurrent Marginal Zone Lymphoma (protocolSection.conditionsModule.conditions)
• Recurrent Small Lymphocytic Lymphoma (protocolSection.conditionsModule.conditions)
• Refractory Hairy Cell Leukemia (protocolSection.conditionsModule.conditions)
• Refractory Multiple Myeloma (protocolSection.conditionsModule.conditions)
• Small Intestine Lymphoma (protocolSection.conditionsModule.conditions)
• Splenic Marginal Zone Lymphoma (protocolSection.conditionsModule.conditions)
• Stage I Adult Burkitt Lymphoma (protocolSection.conditionsModule.conditions)
• Stage I Adult Diffuse Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Stage I Adult Diffuse Mixed Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Stage I Adult Diffuse Small Cleaved Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Stage I Adult Immunoblastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Stage I Adult Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
• Stage I Grade 1 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
• Stage I Grade 2 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
• Stage I Grade 3 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
• Stage I Mantle Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Stage I Marginal Zone Lymphoma (protocolSection.conditionsModule.conditions)
• Stage I Multiple Myeloma (protocolSection.conditionsModule.conditions)
• Stage I Small Lymphocytic Lymphoma (protocolSection.conditionsModule.conditions)
• Stage II Multiple Myeloma (protocolSection.conditionsModule.conditions)
• Stage III Adult Burkitt Lymphoma (protocolSection.conditionsModule.conditions)
• Stage III Adult Diffuse Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Stage III Adult Diffuse Mixed Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Stage III Adult Diffuse Small Cleaved Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Stage III Adult Immunoblastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Stage III Adult Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
• Stage III Grade 1 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
• Stage III Grade 2 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
• Stage III Grade 3 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
• Stage III Mantle Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Stage III Marginal Zone Lymphoma (protocolSection.conditionsModule.conditions)
• Stage III Multiple Myeloma (protocolSection.conditionsModule.conditions)
• Stage III Small Lymphocytic Lymphoma (protocolSection.conditionsModule.conditions)
• Stage IV Adult Burkitt Lymphoma (protocolSection.conditionsModule.conditions)
• Stage IV Adult Diffuse Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Stage IV Adult Diffuse Mixed Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Stage IV Adult Diffuse Small Cleaved Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Stage IV Adult Immunoblastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Stage IV Adult Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
• Stage IV Grade 1 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
• Stage IV Grade 2 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
• Stage IV Grade 3 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
• Stage IV Mantle Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Stage IV Marginal Zone Lymphoma (protocolSection.conditionsModule.conditions)
• Stage IV Small Lymphocytic Lymphoma (protocolSection.conditionsModule.conditions)
• Untreated Hairy Cell Leukemia (protocolSection.conditionsModule.conditions)
• Waldenström Macroglobulinemia (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.